Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia: A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)
Hematology and Cell Therapy · 1996
DOI: 10.1007/s00282-996-0169-7 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Hematology and Cell Therapy, 1996. Verfasst von G Michel und 17 weiteren Autor:innen. Beteiligte Einrichtung: Service d'Hématologie Pédiatrique, Hôpital d'Enfants la Timone, Marseille, France. Hauptthemen laut MEDLINE: Bone Marrow Transplantation. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
In the LAME89/91 protocol, children with acute myeloid leukemia (AML) who achieved complete remission (CR) after induction chemotherapy, were treated either with allogeneic bone marrow transplantation (BMT) if they had an HLA-compatible related donor or with chemotherapy including high-dose cytarabine. The objectives of this study were to describe the overall results of this strategy and to compare the two post-remission arms. Two hundred and thirty-one children were enrolled in the protocol. Induction chemotherapy consisted of a combination of cytarabine and mitoxantrone. A CR was achieved in 204 children (88%).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Service d'Hématologie Pédiatrique, Hôpital d'Enfants la Timone, Marseille, France.
Zitieren
APA
Michel, G., Baruchel, A., Tabone, M. D., Nelken, B., Leblanc, T., Thuret, I., Bordigoni, P., Bergeron, C., Esperou-Bourdeau, H., Perel, Y., Vannier, J. P., De Lumley, L., Dommergues, J. P., Lamagnère, J. P., Couillaud, G., Auvrignon, A., Schaison, G., & Leverger, G. (1996). Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia: A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Hematology and Cell Therapy. https://doi.org/10.1007/s00282-996-0169-7
Vancouver
Michel G, Baruchel A, Tabone MD, Nelken B, Leblanc T, Thuret I, et al. Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia: A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Hematology and Cell Therapy. 1996. doi:10.1007/s00282-996-0169-7
BibTeX
@article{Michel1996,
author = {Michel, G and Baruchel, A and Tabone, M D and Nelken, B and Leblanc, T and Thuret, I and Bordigoni, P and Bergeron, C and Esperou-Bourdeau, H and Perel, Y and Vannier, J P and De Lumley, L and Dommergues, J P and Lamagnère, J P and Couillaud, G and Auvrignon, A and Schaison, G and Leverger, G},
title = {Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia: A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)},
journal = {Hematology and Cell Therapy},
year = {1996},
doi = {10.1007/s00282-996-0169-7}
}
EUVIMED